Hennepin Healthcare clinical trials study drug that could treat COVID-19 patients

Researchers at Hennepin Healthcare are joining sites across the world in studying a drug that could help patients who have COVID-19.



The clinical trials now underway at Hennepin Healthcare will study hospitalized patients with severe and moderate cases of COVID-19. They'll get an IV of remdesivir, an experimental antiviral drug. It was created to treat Ebola, but wasn't effective for that disease.











Welcome to the official YouTube channel of KARE 11 News. Subscribe to our channel for compelling and dramatic storytelling, award winning investigations, breaking news and information you can use.



» Subscribe to KARE 11 on YouTube:

» Watch more KARE 11 video:

» Visit KARE11.com:

» Download our app!

» Find KARE 11 on Facebook:

» Follow KARE 11 on Twitter:

» Follow KARE 11 on Instagram:

coronavirus,COVID-19 treatment,jennifer austin kare 11,COVID-19 Minnesota,coronavirus minnesota,coronavirus pandemic,remdesivir,Hennepin Healthcare,